Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders - PubMed (original) (raw)
Review
Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders
Marie Lodén. Am J Clin Dermatol. 2003.
Abstract
Emollients and moisturizing creams are used to break the dry skin cycle and to maintain the smoothness of the skin. The term 'moisturizer' is often used synonymously with emollient, but moisturizers often contain humectants in order to hydrate the stratum corneum. Dryness is frequently linked to an impaired barrier function observed, for example, in atopic skin, psoriasis, ichthyosis, and contact dermatitis. Dryness and skin barrier disorders are not a single entity, but are characterized by differences in chemistry and morphology in the epidermis. Large differences also exist between moisturizing creams. Moisturizers have multiple functions apart from moistening the skin. Similar to other actives, the efficacy is likely to depend on the dosage, where compliance is a great challenge faced in the management of skin diseases. Strong odor from ingredients and greasy compositions may be disagreeable to the patients. Furthermore, low pH and sensory reactions, from lactic acid and urea for example, may reduce patient acceptance. Once applied to the skin, the ingredients can stay on the surface, be absorbed into the skin, be metabolized, or disappear from the surface by evaporation, sloughing off, or by contact with other materials. In addition to substances considered as actives, e.g. fats and humectants, moisturizers contain substances conventionally considered as excipients (e.g. emulsifiers, antioxidants, preservatives). Recent findings indicate that actives and excipients may have more pronounced effects in the skin than previously considered. Some formulations may deteriorate the skin condition, whereas others improve the clinical appearance and skin barrier function. For example, emulsifiers may weaken the barrier. On the other hand, petrolatum has an immediate barrier-repairing effect in delipidized stratum corneum. Moreover, one ceramide-dominant lipid mixture improved atopic dermatitis and decreased transepidermal water loss (TEWL) in an open-label study in children. In double-blind studies moisturizers with urea have been shown to reduce TEWL in atopic and ichthyotic patients. Urea also makes normal and atopic skin less susceptible against irritation to sodium laurilsulfate. Treatments improving the barrier function may reduce the likelihood of further aggravation of the disease. In order to have optimum effect it is conceivable that moisturizers should be tailored with respect to the epidermal abnormality. New biochemical approaches and non-invasive instruments will increase our understanding of skin barrier disorders and facilitate optimum treatments. The chemistry and function of dry skin and moisturizers is a challenging subject for the practicing dermatologist, as well as for the chemist developing these agents in the pharmaceutical/cosmetic industry.
Similar articles
- The clinical benefit of moisturizers.
Lodén M. Lodén M. J Eur Acad Dermatol Venereol. 2005 Nov;19(6):672-88; quiz 686-7. doi: 10.1111/j.1468-3083.2005.01326.x. J Eur Acad Dermatol Venereol. 2005. PMID: 16268870 Review. - Effect of moisturizers on epidermal barrier function.
Lodén M. Lodén M. Clin Dermatol. 2012 May-Jun;30(3):286-96. doi: 10.1016/j.clindermatol.2011.08.015. Clin Dermatol. 2012. PMID: 22507043 - Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review.
Lindh JD, Bradley M. Lindh JD, et al. Am J Clin Dermatol. 2015 Oct;16(5):341-59. doi: 10.1007/s40257-015-0146-4. Am J Clin Dermatol. 2015. PMID: 26267423 Review. - Moisturizers: reality and the skin benefits.
Nolan K, Marmur E. Nolan K, et al. Dermatol Ther. 2012 May-Jun;25(3):229-33. doi: 10.1111/j.1529-8019.2012.01504.x. Dermatol Ther. 2012. PMID: 22913439 - Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial.
Buraczewska I, Berne B, Lindberg M, Törmä H, Lodén M. Buraczewska I, et al. Br J Dermatol. 2007 Mar;156(3):492-8. doi: 10.1111/j.1365-2133.2006.07685.x. Br J Dermatol. 2007. PMID: 17300239 Clinical Trial.
Cited by
- Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review.
Jacobi A, Mayer A, Augustin M. Jacobi A, et al. Dermatol Ther (Heidelb). 2015 Mar;5(1):1-18. doi: 10.1007/s13555-015-0068-3. Epub 2015 Jan 21. Dermatol Ther (Heidelb). 2015. PMID: 25604924 Free PMC article. - Hydration status regulates sodium flux and inflammatory pathways through epithelial sodium channel (ENaC) in the skin.
Xu W, Hong SJ, Zeitchek M, Cooper G, Jia S, Xie P, Qureshi HA, Zhong A, Porterfield MD, Galiano RD, Surmeier DJ, Mustoe TA. Xu W, et al. J Invest Dermatol. 2015 Mar;135(3):796-806. doi: 10.1038/jid.2014.477. Epub 2014 Nov 5. J Invest Dermatol. 2015. PMID: 25371970 - In vivo examination of healthy human skin after short-time treatment with moisturizers using confocal Raman spectroscopy and optical coherence tomography: Preliminary observations.
Ruini C, Kendziora B, Ergun EZ, Sattler E, Gust C, French LE, Bağcı IS, Hartmann D. Ruini C, et al. Skin Res Technol. 2022 Jan;28(1):119-132. doi: 10.1111/srt.13101. Epub 2021 Sep 23. Skin Res Technol. 2022. PMID: 34555219 Free PMC article. - Polymeric Gels and Their Application in the Treatment of Psoriasis Vulgaris: A Review.
Kulawik-Pióro A, Miastkowska M. Kulawik-Pióro A, et al. Int J Mol Sci. 2021 May 12;22(10):5124. doi: 10.3390/ijms22105124. Int J Mol Sci. 2021. PMID: 34066105 Free PMC article. Review. - [Therapy of atopic dermatitis].
Abels C, Proksch E. Abels C, et al. Hautarzt. 2006 Aug;57(8):711-23; quiz 724-5. doi: 10.1007/s00105-006-1176-x. Hautarzt. 2006. PMID: 16816954 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources